| 000 | 01763 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514034126.0 | ||
| 264 | 0 | _c20021120 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0192-6233 | ||
| 024 | 7 |
_a10.1080/01926230252929882 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVahle, John L | |
| 245 | 0 | 0 |
_aSkeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. _h[electronic resource] |
| 260 |
_bToxicologic pathology _c |
||
| 300 |
_a312-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperplasia _xchemically induced |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOsteoblastoma _xchemically induced |
| 650 | 0 | 4 |
_aOsteoma _xchemically induced |
| 650 | 0 | 4 |
_aOsteosarcoma _xchemically induced |
| 650 | 0 | 4 |
_aParathyroid Hormone _xadministration & dosage |
| 650 | 0 | 4 |
_aPeptide Fragments _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSato, Masahiko | |
| 700 | 1 | _aLong, Gerald G | |
| 700 | 1 | _aYoung, Jamie K | |
| 700 | 1 | _aFrancis, Paul C | |
| 700 | 1 | _aEngelhardt, Jeffery A | |
| 700 | 1 | _aWestmore, Michael S | |
| 700 | 1 | _aLinda, Yanfei | |
| 700 | 1 | _aNold, James B | |
| 773 | 0 |
_tToxicologic pathology _gvol. 30 _gno. 3 _gp. 312-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/01926230252929882 _zAvailable from publisher's website |
| 999 |
_c11947769 _d11947769 |
||